ABBV vs. MO
ABBV (AbbVie Inc.) and MO (Altria Group, Inc.) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while MO operates in Tobacco (Consumer Defensive). Over the past 10 years, ABBV returned 18.45%/yr vs 8.10%/yr for MO. At a 0.28 correlation, their price movements are largely independent.
Performance
ABBV vs. MO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a 1.08% return, which is significantly lower than MO's 27.30% return. Over the past 10 years, ABBV has outperformed MO with an annualized return of 18.45%, while MO has yielded a comparatively lower 8.10% annualized return.
ABBV
- 1D
- 1.02%
- 1M
- 10.83%
- YTD
- 1.08%
- 6M
- 2.16%
- 1Y
- 25.16%
- 3Y*
- 23.16%
- 5Y*
- 19.52%
- 10Y*
- 18.45%
MO
- 1D
- 2.25%
- 1M
- 2.88%
- YTD
- 27.30%
- 6M
- 28.89%
- 1Y
- 30.10%
- 3Y*
- 26.90%
- 5Y*
- 16.44%
- 10Y*
- 8.10%
ABBV vs. MO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 1.08% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
MO Altria Group, Inc. | 27.30% | 18.17% | 40.76% | -3.70% | 4.37% | 24.18% | -10.21% | 7.87% | -27.14% | 9.45% |
Correlation
The correlation between ABBV and MO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013 | 0.28 |
The correlation between ABBV and MO shifts across timeframes, from 0.15 (1 year) to 0.31 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ABBV:
$403.11B
MO:
$120.77B
ABBV:
$2.05
MO:
$4.79
ABBV:
110.71
MO:
15.06
ABBV:
6.41
MO:
5.56
ABBV:
$62.82B
MO:
$21.82B
ABBV:
$46.15B
MO:
$14.80B
ABBV:
$17.96B
MO:
$11.70B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. MO — Risk / Return Rank
ABBV
MO
ABBV vs. MO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABBV | MO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.30 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.26 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 1.46 | 1.84 | -0.38 |
| Martin ratioReturn relative to average drawdown | 3.27 | 4.65 | -1.38 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABBV | MO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.04 | 1.35 | -0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.86 | 0.80 | +0.06 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.72 | 0.35 | +0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.75 | 0.70 | +0.05 |
Drawdowns
ABBV vs. MO - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum MO drawdown of -65.43%. Use the drawdown chart below to compare losses from any high point for ABBV and MO.
Loading charts...
Drawdown Indicators
| ABBV | MO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -65.43% | +20.34% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -16.40% | -0.92% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -16.40% | -4.34% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -25.83% | +3.91% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -53.69% | +8.60% |
Current DrawdownCurrent decline from peak | -4.81% | -3.17% | -1.64% |
Average DrawdownAverage peak-to-trough decline | -10.72% | -11.93% | +1.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.71% | 6.48% | +1.23% |
Volatility
ABBV vs. MO - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 6.15%, while Altria Group, Inc. (MO) has a volatility of 6.78%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | MO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.15% | 6.78% | -0.63% |
Volatility (6M)Calculated over the trailing 6-month period | 17.80% | 17.26% | +0.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.23% | 22.45% | +1.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 20.64% | +2.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.74% | 22.95% | +2.79% |
Dividends
ABBV vs. MO - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.97%, less than MO's 5.82% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.97% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
MO Altria Group, Inc. | 5.82% | 7.21% | 7.65% | 9.52% | 8.05% | 7.43% | 8.29% | 6.57% | 6.07% | 3.56% | 3.48% | 3.73% |
Financials
ABBV vs. MO - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Altria Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. MO - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
MO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported a gross profit of 3.51B and revenue of 5.43B. Therefore, the gross margin over that period was 64.6%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
MO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported an operating income of 2.96B and revenue of 5.43B, resulting in an operating margin of 54.5%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
MO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported a net income of 2.18B and revenue of 5.43B, resulting in a net margin of 40.2%.
Frequently Asked Questions
ABBV and MO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MO has higher volatility (6.78%) compared to ABBV (6.15%). In terms of maximum drawdown, ABBV dropped -45.09% vs MO's -65.43%.
MO currently has the higher Sharpe Ratio (1.35 vs 1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and MO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer